Enfuvirtide prescription at the end of pregnancy to a multi-treated HIV-infected woman with virological breakthrough [2]

AIDS

Volumn 18, Issue 14, 2004, Pages 1966-1968

  Meyohas, Marie Caroline ^a   Lacombe, Karine ^a   Carbonne, Bruno ^a   Morand Joubert, Laurence ^a   Girard, Pierre Marie ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; CD4 ANTIGEN; DIDANOSINE; ENFUVIRTIDE; INDINAVIR; LAMIVUDINE; LOPINAVIR; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; RITONAVIR; RNA DIRECTED DNA POLYMERASE; SAQUINAVIR; STAVUDINE; TENOFOVIR; VIRUS RNA; ZIDOVUDINE;

ADULT; ADVERSE DRUG REACTION; CASE REPORT; COMBINATION CHEMOTHERAPY; DRUG POTENTIATION; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LIPODYSTROPHY; LYMPHOCYTE; MOTHER FETUS RELATIONSHIP; MULTIDRUG RESISTANCE; PREGNANT WOMAN; PRESCRIPTION; PRIORITY JOURNAL; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; ANTI-HIV AGENTS; DRUG RESISTANCE, MULTIPLE, VIRAL; FEMALE; HIV ENVELOPE PROTEIN GP41; HIV FUSION INHIBITORS; HIV INFECTIONS; HUMANS; MUTATION; PEPTIDE FRAGMENTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 4744362280     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200409240-00017     Document Type: Letter

References (4)

1. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al., for the Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994; 331:1173-1180.
2. Cooper ER, Charurat M, Mofeson L, Hanson IC, Pitt J, Diaz C, et al., for the Women and Infants' Transmission Study Group. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquired Immune Defic Syndr 2002; 29: 484-494.
3. Lalezari JP, Henry K, O'Hearn M, Montaner JS, Piliero PJ, Trottier B, et al., for the TORO 1 Study Group. Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in north and south America. N Engl J Med 2003; 348:2175-2185.
4. Lazzarin A, Clotet B, Cooper D, Reynes J, Arastéh K, Nelson M, et al., for the TORO 2 Study Group. Efficacity of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia. N Engl J Med 2003; 348:2186-2195